184 related articles for article (PubMed ID: 34152098)
21. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
22. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
[TBL] [Abstract][Full Text] [Related]
23. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
[TBL] [Abstract][Full Text] [Related]
24. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
[TBL] [Abstract][Full Text] [Related]
25. Correlations of TNM staging and lymph node metastasis of gastric cancer with MRI features and VEGF expression.
Pang L; Wang J; Fan Y; Xu R; Bai Y; Bai L
Cancer Biomark; 2018; 23(1):53-59. PubMed ID: 30010108
[TBL] [Abstract][Full Text] [Related]
26. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
[TBL] [Abstract][Full Text] [Related]
27. Tumor volume of resectable adenocarcinoma of the esophagogastric junction at multidetector CT: association with regional lymph node metastasis and N stage.
Li R; Chen TW; Hu J; Guo DD; Zhang XM; Deng D; Li H; Chen XL; Tang HJ
Radiology; 2013 Oct; 269(1):130-8. PubMed ID: 23657894
[TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan.
Nakamura T; Ide H; Eguchi R; Ota M; Shimizu S; Isono K
Dis Esophagus; 2002; 15(3):219-25. PubMed ID: 12444994
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
30. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
31. The expression of microRNA-34a is inversely correlated with c-MET and CDK6 and has a prognostic significance in lung adenocarcinoma patients.
Hong JH; Roh KS; Suh SS; Lee S; Sung SW; Park JK; Byun JH; Kang JH
Tumour Biol; 2015 Dec; 36(12):9327-37. PubMed ID: 26104764
[TBL] [Abstract][Full Text] [Related]
32. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
33. Factors predicting survival in patients with proximal gastric carcinoma involving the esophagus.
Zhang YF; Shi J; Yu HP; Feng AN; Fan XS; Lauwers GY; Mashimo H; Gold JS; Chen G; Huang Q
World J Gastroenterol; 2012 Jul; 18(27):3602-9. PubMed ID: 22826627
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
[TBL] [Abstract][Full Text] [Related]
35. [Surgery treatment and prognosis analysis of 129 small cell carcinoma of the esophagogastric junction].
Li BZ; He M; Chen X; Zhu H; Xu XJ
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):490-496. PubMed ID: 33902213
[No Abstract] [Full Text] [Related]
36. Adenocarcinoma of the esophagogastric junction in Japan.
Yamamoto M; Baba H; Egashira A; Oki E; Ikebe M; Kakeji Y; Maehara Y
Hepatogastroenterology; 2008; 55(81):103-7. PubMed ID: 18507087
[TBL] [Abstract][Full Text] [Related]
37. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
38. Molecular dissection of the chromosome band 7q21 amplicon in gastroesophageal junction adenocarcinomas identifies cyclin-dependent kinase 6 at both genomic and protein expression levels.
van Dekken H; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Wink JC; van Duin M
Genes Chromosomes Cancer; 2008 Aug; 47(8):649-56. PubMed ID: 18438866
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
[TBL] [Abstract][Full Text] [Related]
40. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
